Abiopharma

Director Burak Mallorie Sara 🟢 acquired 6.4K shares of Energous Corp (WATT) at $7.88 Transaction Date: Aug 21, 2025 | Filing ID: 007439

REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C

LivaNova to Host Investor Day on November 12, 2025

Bio-Rad - Bio-Rads Management to Participate in Upcoming Investor Conferences

Cerus Corporation - The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

New Form 15-12G - IGM Biosciences, Inc. Filed: 2025-08-25 AccNo: 0001140361-25-032440 Size: 13 KB

Join Nexalin Technologys Exclusive Live Investor Webinar and Q&A Session on September 9

Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

Gevo to Participate in Virtual Fireside Chat

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

Lilly to participate in Morgan Stanley 23rd Annual Global Healthcare Conference

AbbVie to Acquire Gilgamesh Pharmaceuticals Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

Director Myers Scott Dunseth 🟢 acquired 3.8K shares of DYNAVAX TECHNOLOGIES CORP (DVAX) at $10.82 Transaction Date: Aug 22, 2025 | Filing ID: 000120